GENETICALLY-ENGINEERED DRUG RESISTANT T CELLS AND METHODS OF USING THE SAME Application EP-4295914-A2 European Patent Office 27 Dec 2023
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising… Grant US-11717563-B2 United States of America 08 Aug 2023
GENETICALLY-ENGINEERED DRUG RESISTANT T CELLS AND METHODS OF USING THE SAME Application EP-4006146-A1 European Patent Office 01 Jun 2022
Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of… Grant US-11235069-B2 United States of America 01 Feb 2022
Liposome compositions comprising PAM2Cys or PAM3Cys adjuvant and methods for inducing a… Grant US-11077184-B2 United States of America 03 Aug 2021
Combination immunotherapy for treating cancer Grant US-11071775-B2 United States of America 27 Jul 2021
INCREASING RESPONSES TO CHECKPOINT INHIBITORS BY EXTRACORPOREAL APHERESIS Application WO-2020226633-A1 World Intellectual Property Organisation (WIPO) 12 Nov 2020
Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for… Grant US-10272042-B2 United States of America 30 Apr 2019
Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of… Grant US-10232052-B2 United States of America 19 Mar 2019
Liposome compositions comprising an adjuvant that activates or increases the activity of… Grant US-10105435-B2 United States of America 23 Oct 2018
Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for… Grant US-9925142-B2 United States of America 27 Mar 2018
GENETICALLY-ENGINEERED DRUG RESISTANT T CELLS AND METHODS OF USING THE SAME Application WO-2017041106-A1 World Intellectual Property Organisation (WIPO) 09 Mar 2017
Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of… Grant US-9498493-B2 United States of America 22 Nov 2016
Methods for treating cancer with a recombinant MVA expressing HER-2 Application US-8313740-B2 United States of America 20 Nov 2012
Methods for treating cancer with a recombinant MVA expressing HER-2 Grant US-7807146-B2 United States of America 05 Oct 2010